|
|
||||||||
Biomedical Chemistry Research Center, Department of Chemistry, University of Cincinnati, Cincinnati, Ohio
Correspondence: For reprints contact: Edward Deutsch, Biomedical Chemistry Research Center, Dept. of Chemistry, University of Cincinnati, Cincinnati, OH 45221.
ABSTRACT
Technetium-99m cations are of interest because of their potential use as myocardial perfusion imaging agents. These species can undergo in vivo reactions which markedly affect their biodistribution patterns. Four such cases of reactions are presented and discussed: (1) simple ligand substitution; (2) metal centered redox processes; (3) reactions of coordinated ligands; (4) outer sphere association reactions. New experimental techniques appropriate for investigating these reactions at the 1010M concentration level of technetium encountered in vivo are also presented and discussed. The latter three classes of reactions are illustrated by examples taken from the recent literature and from unpublished data.
FOOTNOTES
Presented as part of the Categorical Seminar "The Chemistry of Radiopharmaceuticals In Vivo: Methods and State of Characterization" at the 33rd annual meeting of the Society of Nuclear Medicine, June 21, 1986, Washington, DC.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |